Literature DB >> 30746772

Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key?

Thomas M Drake1,2, Thomas G Bird1,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30746772      PMCID： PMC6451840          DOI： 10.1111/apt.15119

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  9 in total

1.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

2.  Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

Authors:  Kristina Tzartzeva; Joseph Obi; Nicole E Rich; Neehar D Parikh; Jorge A Marrero; Adam Yopp; Akbar K Waljee; Amit G Singal
Journal:  Gastroenterology       Date:  2018-02-06       Impact factor: 22.682

Review 3.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

Review 4.  Noninvasive assessment of liver fibrosis.

Authors:  Stella M Martínez; Gonzalo Crespo; Miquel Navasa; Xavier Forns
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

5.  Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

Authors:  Thierry Poynard; Julien Vergniol; Yen Ngo; Juliette Foucher; Mona Munteanu; Wassil Merrouche; Massimo Colombo; Vincent Thibault; Eugene Schiff; Clifford A Brass; Janice K Albrecht; Marika Rudler; Olivier Deckmyn; Pascal Lebray; Dominique Thabut; Vlad Ratziu; Victor de Ledinghen
Journal:  J Hepatol       Date:  2013-11-26       Impact factor: 25.083

6.  Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients.

Authors:  Sarah Berhane; Hidenori Toyoda; Toshifumi Tada; Takashi Kumada; Chiaki Kagebayashi; Shinji Satomura; Nora Schweitzer; Arndt Vogel; Michael P Manns; Julia Benckert; Thomas Berg; Maria Ebker; Jan Best; Alexander Dechêne; Guido Gerken; Joerg F Schlaak; Arndt Weinmann; Marcus A Wörns; Peter Galle; Winnie Yeo; Frankie Mo; Stephen L Chan; Helen Reeves; Trevor Cox; Philip Johnson
Journal:  Clin Gastroenterol Hepatol       Date:  2016-01-13       Impact factor: 11.382

7.  Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.

Authors:  Nabihah Tayob; Anna S F Lok; Kim-Anh Do; Ziding Feng
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-07       Impact factor: 11.382

8.  The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.

Authors:  Philip J Johnson; Sarah J Pirrie; Trevor F Cox; Sarah Berhane; Mabel Teng; Daniel Palmer; Janet Morse; Diana Hull; Gillian Patman; Chiaki Kagebayashi; Syed Hussain; Janine Graham; Helen Reeves; Shinji Satomura
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-12       Impact factor: 4.254

9.  Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.

Authors:  Thomas G Bird; Polyxeni Dimitropoulou; Rebecca M Turner; Sara J Jenks; Pearce Cusack; Shiying Hey; Andrew Blunsum; Sarah Kelly; Catharine Sturgeon; Peter C Hayes; Sheila M Bird
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240
  9 in total
  1 in total

1.  Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver Cancer.

Authors:  Chuanwen Yu; Chuang Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-07       Impact factor: 2.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.